Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2016.04.029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-Small-Cell Lung Cancer in Stages IIIb and IV

Medicinski Arhiv
Medicine
2014English

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Prognostic Value of KRAS/TP53/PIK3CA in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer

Journal of Clinical & Cellular Immunology
2014English

BAP1 Is a Good Prognostic Factor in Advanced Non-Small Cell Lung Cancer

Clinical and Investigative Medicine
Medicine
2012English

Sex as an Independent Prognostic Factor in a Population-Based, Non-Small Cell Lung Cancer Cohort

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value

ISRN Molecular Biology
2012English

P3.01-10 Dyspnea as a Prognostic Factor in Hispanic Patients With Non-Small Cell Lung Cancer Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of CD276 in Non-Small Cell Lung Cancer

Open Medicine (Poland)
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy